Atopic Eczema Treatment Market [2023-2030] Leading

The Atopic Dermatitis Global Market Report 2023 by The Business Research Company, provides atopic dermatitis market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Atopic Dermatitis Market:

https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report

According to The Business Research Company’s Atopic Dermatitis Global Market Report 2023, the market size is expected to grow from $6.48 billion in 2022 to $7.51 billion in 2023 at a compound annual growth rate (CAGR) of 15.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The atopic dermatitis market is expected to grow to $13.06 billion in 2027 at a CAGR of 14.9%.

The high prevalence of atopic dermatitis is expected to propel the growth of the atopic dermatitis market forward. Atopic dermatitis, also called eczema, is a skin condition that causes dryness and itchiness of the skin. The increasing prevalence of atopic dermatitis increases the need for diagnosis and treatment of the disease.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=8285&type=smp

The atopic dermatitis market is segmented:

1) By Drug Class: Corticosteroids, Emollients/Moisturizers, IL-4 and PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes

2) By Mode of Administration: Topical, Injectable, Oral

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Product innovations are a key trend gaining popularity in the atopic dermatitis market. Major companies in the market are introducing innovative products to strengthen their market position. For instance, in May 2020, Sanofi, a France-based pharmaceutical company, received FDA approval for its novel dupilumab drug Dupixent for the treatment of moderate-to-severe atopic dermatitis. It is the first and only biologic drug to receive approval for treating atopic dermatitis in children between the ages of 6 and 11. Children treated with it achieved clearer skin in just 16 weeks in the phase 3 trial, which was better than topical corticosteroids alone.

The atopic dermatitis market report table of contents includes:

1. Executive Summary
2. Atopic Dermatitis Market Characteristics
3. Atopic Dermatitis Market Trends And Strategies
4. Atopic Dermatitis Market – Macro Economic Scenario
5. Atopic Dermatitis Market Size And Growth

.

.

.

26. Africa Atopic Dermatitis Market
27. Atopic Dermatitis Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Atopic Dermatitis Market
29. Atopic Dermatitis Market Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model